,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1302690,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,5420,PODXL,https://ctdbase.org/detail.go?type=gene&acc=5420,,,5420.0,PODXL,9606,Homo sapiens (human),Silicon dioxide analog results in increased expression of PODXL mRNA,,,PMID:25895662,https://www.ncbi.nlm.nih.gov/pubmed/25895662,25895662,,
1,1302691,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,79983,POF1B,https://ctdbase.org/detail.go?type=gene&acc=79983,,,79983.0,POF1B,9606,Homo sapiens (human),Silicon dioxide analog results in decreased expression of POF1B mRNA,,,PMID:25895662,https://www.ncbi.nlm.nih.gov/pubmed/25895662,25895662,,
2,1302209,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,2645,GCK,https://ctdbase.org/detail.go?type=gene&acc=2645,,,2645.0,GCK,10090,Mus musculus (house mouse),[streptozocin co-treated with dietary fats co-treated with diethylhexyl phthalate] results in decreased expression of GCK protein|[streptozocin co-treated with dietary fats] results in decreased expression of GCK protein,,,PMID:33484791,https://www.ncbi.nlm.nih.gov/pubmed/33484791,33484791,,
3,1369728,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Metformin inhibits the reaction [[streptozocin co-treated with dietary fats] results in decreased expression of NFE2L2 protein]|glyburide inhibits the reaction [[streptozocin co-treated with dietary fats] results in decreased expression of NFE2L2 protein]|dimethyl fumarate inhibits the reaction [[streptozocin co-treated with dietary fats] results in decreased expression of NFE2L2 protein]|[glyburide co-treated with dimethyl fumarate] inhibits the reaction [[streptozocin co-treated with dietary fats] results in decreased expression of NFE2L2 protein],,,PMID:36999408,https://www.ncbi.nlm.nih.gov/pubmed/36999408,36999408,,
4,1369729,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Diphenyldiselenide inhibits the reaction [streptozocin results in decreased expression of NFE2L2 mrna]|diphenyldiselenide inhibits the reaction [streptozocin results in decreased expression of NFE2L2 protein]|metformin inhibits the reaction [streptozocin results in decreased expression of NFE2L2 protein],,,PMID:33639173,https://www.ncbi.nlm.nih.gov/pubmed/33639173,33639173,,
5,1302374,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,23283,CSTF2T,https://ctdbase.org/detail.go?type=gene&acc=23283,,,23283.0,CSTF2T,9606,Homo sapiens (human),Doxorubicin results in decreased expression of CSTF2T mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
6,1302375,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,79096,CSTPP1,https://ctdbase.org/detail.go?type=gene&acc=79096,,,79096.0,CSTPP1,9606,Homo sapiens (human),Doxorubicin results in decreased expression of CSTPP1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
7,1302376,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1486,CTBS,https://ctdbase.org/detail.go?type=gene&acc=1486,,,1486.0,CTBS,9606,Homo sapiens (human),Doxorubicin results in decreased expression of CTBS mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
8,1302518,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,51596,CUTA,https://ctdbase.org/detail.go?type=gene&acc=51596,,,51596.0,CUTA,9606,Homo sapiens (human),Doxorubicin affects the expression of CUTA protein,,,PMID:29385562,https://www.ncbi.nlm.nih.gov/pubmed/29385562,29385562,,
9,1302519,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,23316,CUX2,https://ctdbase.org/detail.go?type=gene&acc=23316,,,23316.0,CUX2,9606,Homo sapiens (human),Doxorubicin results in increased expression of CUX2 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
10,1302520,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606,Homo sapiens (human),[[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [doxorubicin results in increased activity of CASP3 protein]|resveratrol inhibits the reaction [[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to doxorubicin]|[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to doxorubicin|[[[[hyaluronic acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [doxorubicin results in increased activity of CASP3 protein],,,PMID:19047049,https://www.ncbi.nlm.nih.gov/pubmed/19047049,19047049,,
11,1302207,33184,Comparative Toxicogenomics Database (CTD),Azoxymethane,D001397,Azoxymethane,https://ctdbase.org/detail.go?type=chem&acc=D001397,5588,PRKCQ,https://ctdbase.org/detail.go?type=gene&acc=5588,,,5588.0,PRKCQ,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of PRKCQ mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
12,1302208,33184,Comparative Toxicogenomics Database (CTD),Azoxymethane,D001397,Azoxymethane,https://ctdbase.org/detail.go?type=chem&acc=D001397,5593,PRKG2,https://ctdbase.org/detail.go?type=gene&acc=5593,,,5593.0,PRKG2,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of PRKG2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
13,1302692,33184,Comparative Toxicogenomics Database (CTD),Azoxymethane,D001397,Azoxymethane,https://ctdbase.org/detail.go?type=chem&acc=D001397,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Azoxymethane results in increased expression of PTGS2 protein|ursodeoxycholic acid inhibits the reaction [azoxymethane results in increased expression of PTGS2 protein],,,PMID:12496057|PMID:12839936,https://www.ncbi.nlm.nih.gov/pubmed/12496057|https://www.ncbi.nlm.nih.gov/pubmed/12839936,12496057|12839936,,
14,1302370,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312.0,HSPA8,10090,Mus musculus (house mouse),Deoxynivalenol results in increased phosphorylation of HSPA8 protein,,,PMID:23811945,https://www.ncbi.nlm.nih.gov/pubmed/23811945,23811945,,
15,1302371,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312.0,HSPA8,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of HSPA8 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
16,1302372,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of HSPB1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
17,1302373,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,126393,HSPB6,https://ctdbase.org/detail.go?type=gene&acc=126393,,,126393.0,HSPB6,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of HSPB6 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
18,1302521,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,80262,PHAF1,https://ctdbase.org/detail.go?type=gene&acc=80262,,,80262.0,PHAF1,9606,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of PHAF1 protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
19,1302522,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,51131,PHF11,https://ctdbase.org/detail.go?type=gene&acc=51131,,,51131.0,PHF11,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of PHF11 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
20,1302523,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26147,PHF19,https://ctdbase.org/detail.go?type=gene&acc=26147,,,26147.0,PHF19,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of PHF19 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
21,1302524,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,55023,PHIP,https://ctdbase.org/detail.go?type=gene&acc=55023,,,55023.0,PHIP,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of PHIP mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
22,1302525,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,5260,PHKG1,https://ctdbase.org/detail.go?type=gene&acc=5260,,,5260.0,PHKG1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of PHKG1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
23,1458645,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,137970,UNC5D,https://ctdbase.org/detail.go?type=gene&acc=137970,,,137970.0,UNC5D,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of UNC5D mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
24,1458646,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,51733,UPB1,https://ctdbase.org/detail.go?type=gene&acc=51733,,,51733.0,UPB1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of UPB1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
25,1458647,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,65110,UPF3A,https://ctdbase.org/detail.go?type=gene&acc=65110,,,65110.0,UPF3A,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of UPF3A mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
26,1458648,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7378,UPP1,https://ctdbase.org/detail.go?type=gene&acc=7378,,,7378.0,UPP1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of UPP1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
27,1418361,68740,Comparative Toxicogenomics Database (CTD),Zoledronic acid,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,55203,LGI2,https://ctdbase.org/detail.go?type=gene&acc=55203,,,55203.0,LGI2,9606,Homo sapiens (human),Zoledronic acid results in decreased expression of LGI2 mRNA,,,PMID:24714768,https://www.ncbi.nlm.nih.gov/pubmed/24714768,24714768,,
28,1418362,68740,Comparative Toxicogenomics Database (CTD),Zoledronic acid,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,10186,LHFPL6,https://ctdbase.org/detail.go?type=gene&acc=10186,,,10186.0,LHFPL6,9606,Homo sapiens (human),Zoledronic acid results in increased expression of LHFPL6 mRNA,,,PMID:24714768,https://www.ncbi.nlm.nih.gov/pubmed/24714768,24714768,,
29,1459086,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of PHLDA1 mrna|flusilazole results in decreased expression of PHLDA1 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
30,1459087,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5293,PIK3CD,https://ctdbase.org/detail.go?type=gene&acc=5293,,,5293.0,PIK3CD,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of PIK3CD mrna|flusilazole results in decreased expression of PIK3CD mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
31,1457538,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5688,PSMA7,https://ctdbase.org/detail.go?type=gene&acc=5688,,,5688.0,PSMA7,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMA7 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
32,1457539,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5690,PSMB2,https://ctdbase.org/detail.go?type=gene&acc=5690,,,5690.0,PSMB2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMB2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
33,1457540,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5691,PSMB3,https://ctdbase.org/detail.go?type=gene&acc=5691,,,5691.0,PSMB3,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMB3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
34,1457541,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5692,PSMB4,https://ctdbase.org/detail.go?type=gene&acc=5692,,,5692.0,PSMB4,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMB4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
35,1457542,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5693,PSMB5,https://ctdbase.org/detail.go?type=gene&acc=5693,,,5693.0,PSMB5,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMB5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
36,1457543,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of PSMB6 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
37,1458469,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,22931,RAB18,https://ctdbase.org/detail.go?type=gene&acc=22931,,,22931.0,RAB18,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB18 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
38,1458470,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5861,RAB1A,https://ctdbase.org/detail.go?type=gene&acc=5861,,,5861.0,RAB1A,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB1A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
39,1458471,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,81876,RAB1B,https://ctdbase.org/detail.go?type=gene&acc=81876,,,81876.0,RAB1B,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAB1B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
40,1458799,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5883,RAD9A,https://ctdbase.org/detail.go?type=gene&acc=5883,,,5883.0,RAD9A,9606,Homo sapiens (human),"[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to RAD9A protein modified form]",,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
41,1458800,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5883,RAD9A,https://ctdbase.org/detail.go?type=gene&acc=5883,,,5883.0,RAD9A,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol inhibits the reaction [ESR1 protein binds to RAD9A protein]",,,PMID:29389661,https://www.ncbi.nlm.nih.gov/pubmed/29389661,29389661,,
42,1458801,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5896,RAG1,https://ctdbase.org/detail.go?type=gene&acc=5896,,,5896.0,RAG1,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAG1 mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
43,1458802,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,26064,RAI14,https://ctdbase.org/detail.go?type=gene&acc=26064,,,26064.0,RAI14,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAI14 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
44,1458803,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5898,RALA,https://ctdbase.org/detail.go?type=gene&acc=5898,,,5898.0,RALA,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RALA protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
45,1458804,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5899,RALB,https://ctdbase.org/detail.go?type=gene&acc=5899,,,5899.0,RALB,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RALB protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
46,1458805,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,22913,RALY,https://ctdbase.org/detail.go?type=gene&acc=22913,,,22913.0,RALY,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RALY protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
47,1458958,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5905,RANGAP1,https://ctdbase.org/detail.go?type=gene&acc=5905,,,5905.0,RANGAP1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RANGAP1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
48,1458959,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5906,RAP1A,https://ctdbase.org/detail.go?type=gene&acc=5906,,,5906.0,RAP1A,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAP1A protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
49,1458960,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,406714,RAP1AB,https://ctdbase.org/detail.go?type=gene&acc=406714,,,406714.0,rap1ab,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of RAP1AB mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
50,1458961,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5908,RAP1B,https://ctdbase.org/detail.go?type=gene&acc=5908,,,5908.0,RAP1B,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of RAP1B mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
51,1458962,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5908,RAP1B,https://ctdbase.org/detail.go?type=gene&acc=5908,,,5908.0,RAP1B,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAP1B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
52,1458963,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5910,RAP1GDS1,https://ctdbase.org/detail.go?type=gene&acc=5910,,,5910.0,RAP1GDS1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAP1GDS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
53,1458964,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5912,RAP2B,https://ctdbase.org/detail.go?type=gene&acc=5912,,,5912.0,RAP2B,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of RAP2B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
54,1458965,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of RARRES1 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
55,1460832,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23788,MTCH2,https://ctdbase.org/detail.go?type=gene&acc=23788,,,23788.0,MTCH2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MTCH2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
56,1460833,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,92140,MTDH,https://ctdbase.org/detail.go?type=gene&acc=92140,,,92140.0,MTDH,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MTDH protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
57,1460834,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,56181,MTFR1L,https://ctdbase.org/detail.go?type=gene&acc=56181,,,56181.0,MTFR1L,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MTFR1L protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
58,1458966,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5805,PTS,https://ctdbase.org/detail.go?type=gene&acc=5805,,,5805.0,PTS,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PTS mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
59,1458967,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PTTG1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
60,1456948,101616,DrugBank,Lobeline,DB05137,Lobeline,https://www.drugbank.ca/drugs/DB05137,BE0002343,Neuronal acetylcholine receptor subunit alpha-9,https://www.drugbank.ca/bio_entities/BE0002343,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,55584.0,CHRNA9,9606,Homo sapiens (human),,,,,,,,
61,1456949,101616,DrugBank,Lobeline,DB05137,Lobeline,https://www.drugbank.ca/drugs/DB05137,BE0000411,Neuronal acetylcholine receptor subunit alpha-10,https://www.drugbank.ca/bio_entities/BE0000411,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,57053.0,CHRNA10,9606,Homo sapiens (human),,,,,,,,
62,1457332,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,327,APEH,https://ctdbase.org/detail.go?type=gene&acc=327,,,327.0,APEH,9606,Homo sapiens (human),Phenylsaligenin cyclic phosphate results in decreased activity of APEH protein,,,PMID:21767566,https://www.ncbi.nlm.nih.gov/pubmed/21767566,21767566,,
63,1457333,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9606,Homo sapiens (human),Phenylsaligenin cyclic phosphate results in decreased activity of BCHE protein,,,PMID:21767566,https://www.ncbi.nlm.nih.gov/pubmed/21767566,21767566,,
64,1457334,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10090,Mus musculus (house mouse),Phenylsaligenin cyclic phosphate results in decreased activity of BCHE protein,,,PMID:9890196,https://www.ncbi.nlm.nih.gov/pubmed/9890196,9890196,,
65,1457335,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [phenylsaligenin cyclic phosphate results in increased activity of CASP3 protein]|phenylmethylsulfonyl fluoride inhibits the reaction [phenylsaligenin cyclic phosphate results in increased activity of CASP3 protein]|acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [phenylsaligenin cyclic phosphate results in increased activity of CASP3 protein]|phenylsaligenin cyclic phosphate results in increased activity of CASP3 protein,,,PMID:11032765,https://www.ncbi.nlm.nih.gov/pubmed/11032765,11032765,,
66,1457336,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,9606,Homo sapiens (human),Phenylsaligenin cyclic phosphate binds to [DDC protein binds to pyridoxal phosphate]|phenylsaligenin cyclic phosphate binds to DDC protein,,,PMID:35151785,https://www.ncbi.nlm.nih.gov/pubmed/35151785,35151785,,
67,1457337,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,2571,GAD1,https://ctdbase.org/detail.go?type=gene&acc=2571,,,2571.0,GAD1,9606,Homo sapiens (human),Phenylsaligenin cyclic phosphate binds to GAD1 protein|phenylsaligenin cyclic phosphate binds to [GAD1 protein binds to pyridoxal phosphate],,,PMID:35151785,https://www.ncbi.nlm.nih.gov/pubmed/35151785,35151785,,
68,1457338,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,2572,GAD2,https://ctdbase.org/detail.go?type=gene&acc=2572,,,2572.0,GAD2,9606,Homo sapiens (human),Phenylsaligenin cyclic phosphate binds to [GAD2 protein binds to pyridoxal phosphate]|phenylsaligenin cyclic phosphate binds to GAD2 protein,,,PMID:35151785,https://www.ncbi.nlm.nih.gov/pubmed/35151785,35151785,,
69,1457339,104885,Comparative Toxicogenomics Database (CTD),"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C046357,phenylsaligenin cyclic phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046357,3067,HDC,https://ctdbase.org/detail.go?type=gene&acc=3067,,,3067.0,HDC,9606,Homo sapiens (human),Phenylsaligenin cyclic phosphate binds to HDC protein|phenylsaligenin cyclic phosphate binds to [HDC protein binds to pyridoxal phosphate],,,PMID:35151785,https://www.ncbi.nlm.nih.gov/pubmed/35151785,35151785,,
70,1456452,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,29988,SLC2A8,https://ctdbase.org/detail.go?type=gene&acc=29988,,,29988.0,SLC2A8,9606,Homo sapiens (human),Glucose inhibits the reaction [SLC2A8 protein results in increased uptake of dehydroascorbic acid],,,PMID:23396969,https://www.ncbi.nlm.nih.gov/pubmed/23396969,23396969,,
71,1456453,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,29988,SLC2A8,https://ctdbase.org/detail.go?type=gene&acc=29988,,,29988.0,SLC2A8,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SLC2A8 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
72,1456454,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,56606,SLC2A9,https://ctdbase.org/detail.go?type=gene&acc=56606,,,56606.0,SLC2A9,9606,Homo sapiens (human),Glucose promotes the reaction [SLC2A9 protein alternative form results in increased transport of uric acid],,,PMID:18842065,https://www.ncbi.nlm.nih.gov/pubmed/18842065,18842065,,
73,1456455,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,56606,SLC2A9,https://ctdbase.org/detail.go?type=gene&acc=56606,,,56606.0,SLC2A9,9606,Homo sapiens (human),SLC2A9 protein results in increased transport of glucose,,,PMID:17710649,https://www.ncbi.nlm.nih.gov/pubmed/17710649,17710649,,
74,1456456,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,7779,SLC30A1,https://ctdbase.org/detail.go?type=gene&acc=7779,,,7779.0,SLC30A1,10116,Rattus norvegicus (Norway rat),"Glucose results in increased expression of SLC30A1 mrna|zinc chloride promotes the reaction [glucose results in increased expression of SLC30A1 mrna]|n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [glucose results in increased expression of SLC30A1 mrna]",,,PMID:23056475,https://www.ncbi.nlm.nih.gov/pubmed/23056475,23056475,,
75,1458649,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9913,Bos taurus (cattle),[SOD2 protein results in decreased chemical synthesis of superoxides] inhibits the reaction [glucose results in decreased phosphorylation of NOS3 protein]|[sod2 protein results in decreased chemical synthesis of superoxides] inhibits the reaction [glucose results in increased O-linked glycosylation of NOS3 protein]|[sod2 protein results in decreased chemical synthesis of superoxides] inhibits the reaction [glucose results in decreased activity of NOS3 protein]|sod2 protein results in decreased susceptibility to glucose,,,PMID:11696579,https://www.ncbi.nlm.nih.gov/pubmed/11696579,11696579,,
76,1458650,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),"Glucose results in decreased expression of and results in decreased activity of SOD2 protein|fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [glucose results in decreased expression of and results in decreased activity of SOD2 protein]]|2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [glucose results in decreased expression of SOD2 protein]]|4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [glucose results in decreased expression of and results in decreased activity of SOD2 protein]",,,PMID:20962025,https://www.ncbi.nlm.nih.gov/pubmed/20962025,20962025,,
77,1458651,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [glucose deficiency affects the folding of SOD2 protein]|cat inhibits the reaction [glucose deficiency affects the folding of SOD2 protein]|glucose deficiency affects the folding of SOD2 protein,,,PMID:17309078,https://www.ncbi.nlm.nih.gov/pubmed/17309078,17309078,,
78,1458652,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Glucose affects the expression of SOD2 mRNA,,,PMID:32942007,https://www.ncbi.nlm.nih.gov/pubmed/32942007,32942007,,
79,1458653,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Glucose deficiency results in decreased expression of SOD2 protein,,,PMID:22314686,https://www.ncbi.nlm.nih.gov/pubmed/22314686,22314686,,
80,1550042,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5814,PURB,https://ctdbase.org/detail.go?type=gene&acc=5814,,,5814.0,PURB,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PURB mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
81,1550043,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,150962,PUS10,https://ctdbase.org/detail.go?type=gene&acc=150962,,,150962.0,PUS10,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of PUS10 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
82,1458203,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,4535,ND1,https://ctdbase.org/detail.go?type=gene&acc=4535,,,4535.0,ND1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of ND1 protein],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
83,1458204,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,4719,NDUFS1,https://ctdbase.org/detail.go?type=gene&acc=4719,,,4719.0,NDUFS1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna]]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [hydrogen peroxide results in decreased expression of NDUFS1 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
84,1458205,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein,,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
85,1458344,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,55500,ETNK1,https://ctdbase.org/detail.go?type=gene&acc=55500,,,55500.0,ETNK1,9606,Homo sapiens (human),Deguelin results in decreased expression of ETNK1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
86,1458345,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2113,ETS1,https://ctdbase.org/detail.go?type=gene&acc=2113,,,2113.0,ETS1,9606,Homo sapiens (human),Deguelin results in increased expression of ETS1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
87,1458346,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2115,ETV1,https://ctdbase.org/detail.go?type=gene&acc=2115,,,2115.0,ETV1,9606,Homo sapiens (human),Deguelin results in decreased expression of ETV1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
88,1458347,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,51466,EVL,https://ctdbase.org/detail.go?type=gene&acc=51466,,,51466.0,EVL,9606,Homo sapiens (human),Deguelin results in decreased expression of EVL mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
89,1458348,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,54512,EXOSC4,https://ctdbase.org/detail.go?type=gene&acc=54512,,,54512.0,EXOSC4,9606,Homo sapiens (human),Deguelin results in decreased expression of EXOSC4 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
90,1458349,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,11340,EXOSC8,https://ctdbase.org/detail.go?type=gene&acc=11340,,,11340.0,EXOSC8,9606,Homo sapiens (human),Deguelin results in increased expression of EXOSC8 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
91,1458350,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,345757,FAM174A,https://ctdbase.org/detail.go?type=gene&acc=345757,,,345757.0,FAM174A,9606,Homo sapiens (human),Deguelin results in decreased expression of FAM174A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
92,1458351,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,729533,FAM72A,https://ctdbase.org/detail.go?type=gene&acc=729533,,,729533.0,FAM72A,9606,Homo sapiens (human),Deguelin results in increased expression of FAM72A mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
93,1458352,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606,Homo sapiens (human),Deguelin results in increased expression of FAS mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
94,1458353,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,9606,Homo sapiens (human),Deguelin results in decreased expression of FASN mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
95,1432872,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,9332,CD163,https://ctdbase.org/detail.go?type=gene&acc=9332,,,9332.0,CD163,9606,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CD163 mRNA",,,PMID:32790152,https://www.ncbi.nlm.nih.gov/pubmed/32790152,32790152,,
96,1456596,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,667,DST,https://ctdbase.org/detail.go?type=gene&acc=667,,,667.0,DST,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DST protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
97,1456597,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,79659,DYNC2H1,https://ctdbase.org/detail.go?type=gene&acc=79659,,,79659.0,DYNC2H1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DYNC2H1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
98,1456598,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8655,DYNLL1,https://ctdbase.org/detail.go?type=gene&acc=8655,,,8655.0,DYNLL1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DYNLL1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
99,1456599,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,6993,DYNLT1,https://ctdbase.org/detail.go?type=gene&acc=6993,,,6993.0,DYNLT1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DYNLT1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
100,1456600,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of E2F1 mRNA,,,PMID:30796839,https://www.ncbi.nlm.nih.gov/pubmed/30796839,30796839,,
101,1456601,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1891,ECH1,https://ctdbase.org/detail.go?type=gene&acc=1891,,,1891.0,ECH1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of ECH1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
102,1456602,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,80267,EDEM3,https://ctdbase.org/detail.go?type=gene&acc=80267,,,80267.0,EDEM3,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of EDEM3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
103,1456603,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9521,EEF1E1,https://ctdbase.org/detail.go?type=gene&acc=9521,,,9521.0,EEF1E1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of EEF1E1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
104,1457082,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of EPHX2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
105,1457083,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9852,EPM2AIP1,https://ctdbase.org/detail.go?type=gene&acc=9852,,,9852.0,EPM2AIP1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of EPM2AIP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
106,1457084,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,29924,EPN1,https://ctdbase.org/detail.go?type=gene&acc=29924,,,29924.0,EPN1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of EPN1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
107,1457085,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2060,EPS15,https://ctdbase.org/detail.go?type=gene&acc=2060,,,2060.0,EPS15,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of EPS15 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
108,1457086,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,58513,EPS15L1,https://ctdbase.org/detail.go?type=gene&acc=58513,,,58513.0,EPS15L1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of EPS15L1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
109,1457887,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2618,GART,https://ctdbase.org/detail.go?type=gene&acc=2618,,,2618.0,GART,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GART protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
110,1457888,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2632,GBE1,https://ctdbase.org/detail.go?type=gene&acc=2632,,,2632.0,GBE1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GBE1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
111,1458029,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,26088,GGA1,https://ctdbase.org/detail.go?type=gene&acc=26088,,,26088.0,GGA1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GGA1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
112,1458030,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8836,GGH,https://ctdbase.org/detail.go?type=gene&acc=8836,,,8836.0,GGH,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GGH protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
113,1458031,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,2689,GH2,https://ctdbase.org/detail.go?type=gene&acc=2689,,,2689.0,GH2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of GH2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
114,1458032,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55303,GIMAP4,https://ctdbase.org/detail.go?type=gene&acc=55303,,,55303.0,GIMAP4,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GIMAP4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
115,1458033,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10755,GIPC1,https://ctdbase.org/detail.go?type=gene&acc=10755,,,10755.0,GIPC1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of GIPC1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
116,1456115,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [gallium nitrate results in increased expression of HMOX1 protein],,,PMID:18586083,https://www.ncbi.nlm.nih.gov/pubmed/18586083,18586083,,
117,1456116,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),SB 203580 inhibits the reaction [kahweol results in increased expression of and results in increased activity of HMOX1 protein],,,PMID:31306736,https://www.ncbi.nlm.nih.gov/pubmed/31306736,31306736,,
118,1456311,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),SB 203580 results in increased expression of HMOX1 mRNA,,,PMID:29796178,https://www.ncbi.nlm.nih.gov/pubmed/29796178,29796178,,
119,1456312,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [10-nitro-oleic acid results in increased expression of HMOX1 mrna]|sb 203580 inhibits the reaction [10-nitro-oleic acid results in increased expression of HMOX1 protein],,,PMID:24140437,https://www.ncbi.nlm.nih.gov/pubmed/24140437,24140437,,
120,1456313,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [17-hydroxyjolkinolide B promotes the reaction [lipopolysaccharides results in increased expression of HMOX1 protein]],,,PMID:22080918,https://www.ncbi.nlm.nih.gov/pubmed/22080918,22080918,,
121,1456314,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMOX1 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
122,1456315,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),"SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mrna]",,,PMID:31029725,https://www.ncbi.nlm.nih.gov/pubmed/31029725,31029725,,
123,1456316,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]|sb 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mrna],,,PMID:24423726,https://www.ncbi.nlm.nih.gov/pubmed/24423726,24423726,,
124,1456317,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [arsenic trioxide results in increased expression of HMOX1 mrna],,,PMID:22488045,https://www.ncbi.nlm.nih.gov/pubmed/22488045,22488045,,
125,1459401,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Magnolin promotes the reaction [SB 203580 inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of IL6 protein]]|sb 203580 promotes the reaction [magnolin inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of IL6 protein]]|sb 203580 promotes the reaction [magnolin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of IL6 mrna]]|sb 203580 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of IL6 mrna]|sb 203580 inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of IL6 protein]|magnolin promotes the reaction [SB 203580 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of IL6 mrna]],,,PMID:30919561,https://www.ncbi.nlm.nih.gov/pubmed/30919561,30919561,,
126,1459402,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),SB 203580 affects the reaction [methotrexate results in decreased expression of IL6 protein],,,PMID:19100307,https://www.ncbi.nlm.nih.gov/pubmed/19100307,19100307,,
127,1459403,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [TNF protein results in increased expression of IL6 mrna]|sb 203580 inhibits the reaction [7-ketocholesterol results in increased expression of IL6 mrna],,,PMID:18515973,https://www.ncbi.nlm.nih.gov/pubmed/18515973,18515973,,
128,1459404,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),SB 203580 inhibits the reaction [cadmium chloride results in increased expression of and results in increased secretion of IL6 protein],,,PMID:35122928,https://www.ncbi.nlm.nih.gov/pubmed/35122928,35122928,,
129,1457207,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,83540,NUF2,https://ctdbase.org/detail.go?type=gene&acc=83540,,,83540.0,NUF2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NUF2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
130,1457208,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,26747,NUFIP1,https://ctdbase.org/detail.go?type=gene&acc=26747,,,26747.0,NUFIP1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NUFIP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
131,1457889,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,8829,NRP1,https://ctdbase.org/detail.go?type=gene&acc=8829,,,8829.0,NRP1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NRP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
132,1457890,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9378,NRXN1,https://ctdbase.org/detail.go?type=gene&acc=9378,,,9378.0,NRXN1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NRXN1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
133,1457891,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9369,NRXN3,https://ctdbase.org/detail.go?type=gene&acc=9369,,,9369.0,NRXN3,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NRXN3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
134,1457892,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,64324,NSD1,https://ctdbase.org/detail.go?type=gene&acc=64324,,,64324.0,NSD1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NSD1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
135,1457893,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,55968,NSFL1C,https://ctdbase.org/detail.go?type=gene&acc=55968,,,55968.0,NSFL1C,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NSFL1C mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
136,1457894,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,64943,NT5DC2,https://ctdbase.org/detail.go?type=gene&acc=64943,,,64943.0,NT5DC2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NT5DC2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
137,1457895,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,23620,NTSR2,https://ctdbase.org/detail.go?type=gene&acc=23620,,,23620.0,NTSR2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NTSR2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
138,1457896,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,81788,NUAK2,https://ctdbase.org/detail.go?type=gene&acc=81788,,,81788.0,NUAK2,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NUAK2 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
139,1457897,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4682,NUBP1,https://ctdbase.org/detail.go?type=gene&acc=4682,,,4682.0,NUBP1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NUBP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
140,1558019,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,10380,BPNT1,https://ctdbase.org/detail.go?type=gene&acc=10380,,,10380.0,BPNT1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of BPNT1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
141,1558020,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,673,BRAF,https://ctdbase.org/detail.go?type=gene&acc=673,,,673.0,BRAF,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of BRAF mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
142,1457209,325597,IUPHAR/BPS Guide to PHARMACOLOGY,"5-(3-Nitrophenyl)-1,3,4-oxathiazol-2-one",8649,HT1042,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8649,2408,proteasome 20S subunit beta 8,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2408,P28062,Proteasome subunit beta type-8,5696.0,PSMB8,9606,Homo sapiens (human),Inhibition,pKi,6.38,PMID:24900849,https://www.ncbi.nlm.nih.gov/pubmed/24900849,24900849,,
143,1457210,327045,Drug Gene Interaction database (DGIdb),Pinafide,,PINAFIDE,https://www.dgidb.org/drugs/ncit:C76757,,POLB,https://www.dgidb.org/genes/hgnc:9174,,,5423.0,POLB,9606,Homo sapiens (human),,,,,,,,
144,1457211,327045,Drug Gene Interaction database (DGIdb),Pinafide,,PINAFIDE,https://www.dgidb.org/drugs/ncit:C76757,,S1PR1,https://www.dgidb.org/genes/hgnc:3165,,,1901.0,S1PR1,9606,Homo sapiens (human),,,,,,,,
145,1457212,327045,Drug Gene Interaction database (DGIdb),Pinafide,,PINAFIDE,https://www.dgidb.org/drugs/ncit:C76757,,PAX8,https://www.dgidb.org/genes/hgnc:8622,,,7849.0,PAX8,9606,Homo sapiens (human),,,,,,,,
146,1457213,327045,Drug Gene Interaction database (DGIdb),Pinafide,,PINAFIDE,https://www.dgidb.org/drugs/ncit:C76757,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606,Homo sapiens (human),,,,,,,,
147,1457214,327045,Drug Gene Interaction database (DGIdb),Pinafide,,PINAFIDE,https://www.dgidb.org/drugs/ncit:C76757,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088.0,SMAD3,9606,Homo sapiens (human),,,,,,,,
148,1457215,328931,Drug Gene Interaction database (DGIdb),4-Amino-5-((5-chloro-1-benzofuran-2-yl)carbonyl)-2-(4-chloro-2-methylanilino)-3-thiophenecarbonitrile,,CHEMBL:CHEMBL552439,https://www.dgidb.org/drugs/chembl:CHEMBL552439,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606,Homo sapiens (human),,,,,,,,
149,1457216,332208,Comparative Toxicogenomics Database (CTD),"2-(3,4,5-Trimethoxyphenyl)-4H-chromen-4-one",C441202,"3',4',5'-trimethoxyflavone",https://ctdbase.org/detail.go?type=chem&acc=C441202,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9823,Sus scrofa (pig),"3',4',5'-trimethoxyflavone analog inhibits the reaction [lipopolysaccharides results in increased expression of CXCL8 mrna]",,,PMID:26180592,https://www.ncbi.nlm.nih.gov/pubmed/26180592,26180592,,
150,1456318,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6372,CXCL6,https://ctdbase.org/detail.go?type=gene&acc=6372,,,6372.0,CXCL6,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of CXCL6 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
151,1458806,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186051,F49E11.7,https://ctdbase.org/detail.go?type=gene&acc=186051,,,186051.0,F49E11.7,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F49E11.7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
152,1458807,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186068,F49F1.12,https://ctdbase.org/detail.go?type=gene&acc=186068,,,186068.0,F49F1.12,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F49F1.12 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
153,1458808,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177177,F49F1.7,https://ctdbase.org/detail.go?type=gene&acc=177177,,,177177.0,F49F1.7,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F49F1.7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
154,1459395,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178741,F54E2.2,https://ctdbase.org/detail.go?type=gene&acc=178741,,,178741.0,F54E2.2,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F54E2.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
155,1459396,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174995,F54F11.1,https://ctdbase.org/detail.go?type=gene&acc=174995,,,174995.0,F54F11.1,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of F54F11.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
156,1459397,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176727,F54F12.1,https://ctdbase.org/detail.go?type=gene&acc=176727,,,176727.0,F54F12.1,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F54F12.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
157,1459398,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186253,F54F7.2,https://ctdbase.org/detail.go?type=gene&acc=186253,,,186253.0,F54F7.2,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F54F7.2 mrna|f54f7.2 protein results in decreased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
158,1459399,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186269,F54H12.5,https://ctdbase.org/detail.go?type=gene&acc=186269,,,186269.0,F54H12.5,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F54H12.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
159,1459400,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,186263,F54H5.2,https://ctdbase.org/detail.go?type=gene&acc=186263,,,186263.0,F54H5.2,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of F54H5.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
160,1549932,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189736,Y39B6A.7,https://ctdbase.org/detail.go?type=gene&acc=189736,,,189736.0,Y39B6A.7,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of Y39B6A.7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
161,1549933,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178565,Y39D8A.1,https://ctdbase.org/detail.go?type=gene&acc=178565,,,178565.0,Y39D8A.1,6239,Caenorhabditis elegans,Y39D8A.1 protein results in decreased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
162,1549934,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176714,Y39E4A.1,https://ctdbase.org/detail.go?type=gene&acc=176714,,,176714.0,Y39E4A.1,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y39E4A.1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
163,1549935,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189755,Y39E4B.11,https://ctdbase.org/detail.go?type=gene&acc=189755,,,189755.0,Y39E4B.11,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of Y39E4B.11 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
164,1458462,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,8336,H2AC17,https://ctdbase.org/detail.go?type=gene&acc=8336,,,8336.0,H2AC17,9606,Homo sapiens (human),Lithium chloride results in decreased expression of H2AC17 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
165,1458463,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,8340,H2BC13,https://ctdbase.org/detail.go?type=gene&acc=8340,,,8340.0,H2BC13,9606,Homo sapiens (human),Lithium chloride results in decreased expression of H2BC13 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
166,1458464,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,8360,H4C4,https://ctdbase.org/detail.go?type=gene&acc=8360,,,8360.0,H4C4,9606,Homo sapiens (human),Lithium chloride results in decreased expression of H4C4 mRNA,,,PMID:15711924,https://www.ncbi.nlm.nih.gov/pubmed/15711924,15711924,,
167,1458465,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,176216,HADB-1,https://ctdbase.org/detail.go?type=gene&acc=176216,,,176216.0,hadb-1,6239,Caenorhabditis elegans,Lithium chloride results in decreased expression of HADB-1 mRNA,,,PMID:25645087,https://www.ncbi.nlm.nih.gov/pubmed/25645087,25645087,,
168,1458466,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1404,HAPLN1,https://ctdbase.org/detail.go?type=gene&acc=1404,,,1404.0,HAPLN1,9606,Homo sapiens (human),Lithium chloride results in increased expression of HAPLN1 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
169,1458467,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065.0,HDAC1,10090,Mus musculus (house mouse),Lithium chloride inhibits the reaction [HDAC1 protein binds to GIP promoter]|lithium chloride inhibits the reaction [HDAC1 protein binds to GCG promoter],,,PMID:19582394,https://www.ncbi.nlm.nih.gov/pubmed/19582394,19582394,,
170,1458468,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,51564,HDAC7,https://ctdbase.org/detail.go?type=gene&acc=51564,,,51564.0,HDAC7,10090,Mus musculus (house mouse),Lithium chloride results in decreased expression of HDAC7 mRNA,,,PMID:26272751,https://www.ncbi.nlm.nih.gov/pubmed/26272751,26272751,,
171,1459562,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3783,KCNN4,https://ctdbase.org/detail.go?type=gene&acc=3783,,,3783.0,KCNN4,9606,Homo sapiens (human),Lithium chloride results in increased expression of KCNN4 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
172,1459563,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3791,KDR,https://ctdbase.org/detail.go?type=gene&acc=3791,,,3791.0,KDR,10090,Mus musculus (house mouse),Lithium chloride results in increased expression of KDR mRNA,,,PMID:26272751,https://www.ncbi.nlm.nih.gov/pubmed/26272751,26272751,,
173,1459564,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3798,KIF5A,https://ctdbase.org/detail.go?type=gene&acc=3798,,,3798.0,KIF5A,9606,Homo sapiens (human),Lithium chloride results in decreased expression of KIF5A mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
174,1457722,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Norepinephrine results in increased expression of ICAM1 mrna|norepinephrine promotes the reaction [NFKB1 protein binds to ICAM1 promoter]|acetylcysteine inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [norepinephrine promotes the reaction [RELA protein binds to ICAM1 promoter]]|norepinephrine promotes the reaction [REL protein binds to ICAM1 promoter]|bisindolylmaleimide I inhibits the reaction [norepinephrine promotes the reaction [REL protein binds to ICAM1 promoter]]|prolinedithiocarbamate inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna]|nfkb1 mutant form inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna]|rel mutant form inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna]|ascorbic acid inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna]|bisindolylmaleimide I inhibits the reaction [norepinephrine promotes the reaction [NFKB1 protein binds to ICAM1 promoter]]|rela mutant form inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna]|vitamin E inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna]|wortmannin inhibits the reaction [norepinephrine promotes the reaction [REL protein binds to ICAM1 promoter]]|norepinephrine promotes the reaction [RELA protein binds to ICAM1 promoter],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
175,1457723,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116,Rattus norvegicus (Norway rat),Prazosin inhibits the reaction [IGF1 protein results in decreased susceptibility to norepinephrine]|igf1 protein results in decreased susceptibility to norepinephrine,,,PMID:17184500,https://www.ncbi.nlm.nih.gov/pubmed/17184500,17184500,,
176,1457724,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [norepinephrine results in increased expression of IL1B mrna]|norepinephrine results in increased expression of IL1B mRNA,,,PMID:10722803,https://www.ncbi.nlm.nih.gov/pubmed/10722803,10722803,,
177,1457725,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Norepinephrine affects the secretion of IL1B protein,,,PMID:16386803,https://www.ncbi.nlm.nih.gov/pubmed/16386803,16386803,,
178,1457726,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Norepinephrine promotes the reaction [IL1B protein results in increased expression of IL6 protein],,,PMID:8392517,https://www.ncbi.nlm.nih.gov/pubmed/8392517,8392517,,
179,1457727,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Norepinephrine results in increased expression of and results in increased secretion of IL6 protein|sulforaphane inhibits the reaction [norepinephrine results in increased expression of and results in increased secretion of IL6 protein],,,PMID:18636164,https://www.ncbi.nlm.nih.gov/pubmed/18636164,18636164,,
180,1457728,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Norepinephrine results in decreased secretion of IL6 protein|anxa1 affects the reaction [norepinephrine results in decreased secretion of IL6 protein],,,PMID:16835395,https://www.ncbi.nlm.nih.gov/pubmed/16835395,16835395,,
181,1457729,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),ICI 118551 inhibits the reaction [norepinephrine results in increased expression of IL6 mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [norepinephrine results in increased expression of IL6 mrna]|propranolol inhibits the reaction [norepinephrine results in increased expression of IL6 mrna],,,PMID:12619890,https://www.ncbi.nlm.nih.gov/pubmed/12619890,12619890,,
182,1493123,441338,Drug Gene Interaction database (DGIdb),Zolpidem Tartrate,,ZOLPIDEM TARTRATE,https://www.dgidb.org/drugs/rxcui:221183,,GABRA3,https://www.dgidb.org/genes/hgnc:4077,,,2556.0,GABRA3,9606,Homo sapiens (human),,,,,,,,
183,1493124,441341,Toxin and Toxin Target Database (T3DB),(2R)-2-(2-oxopyrrolidin-1-yl)butanamide,T3D3019,Levetiracetam,http://www.t3db.ca/toxins/T3D3019,BE0002226,Voltage-dependent N-type calcium channel subunit alpha-1B,http://www.t3db.ca/biodb/bio_entities/BE0002226,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,774.0,CACNA1B,9606,Homo sapiens (human),,,,PMID:17461889|PMID:11879381,https://www.ncbi.nlm.nih.gov/pubmed/17461889|https://www.ncbi.nlm.nih.gov/pubmed/11879381,17461889|11879381,,
184,1493125,441341,Toxin and Toxin Target Database (T3DB),(2R)-2-(2-oxopyrrolidin-1-yl)butanamide,T3D3019,Levetiracetam,http://www.t3db.ca/toxins/T3D3019,BE0000267,Carbonic anhydrase 1,http://www.t3db.ca/biodb/bio_entities/BE0000267,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),"The precise mechanism(s) by which levetiracetam exerts its antiepileptic effect is unknown. the antiepileptic activity of levetiracetam was assessed in a number of animal models of epileptic seizures. levetiracetam did not inhibit single seizures induced by maximal stimulation with electrical current or different chemoconvulsants and showed only minimal activity in submaximal stimulation and in threshold tests. protection was observed, however, against secondarily generalized activity from focal seizures induced by pilocarpine and kainic acid, two chemoconvulsants that induce seizures that mimic some features of human complex partial seizures with secondary generalization. levetiracetam also displayed inhibitory properties in the kindling model in rats, another model of human complex partial seizures, both during kindling development and in the fully kindled state. the predictive value of these animal models for specific types of human epilepsy is uncertain.",,,PMID:18048412,https://www.ncbi.nlm.nih.gov/pubmed/18048412,18048412,,
185,1456105,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,6747,SSR3,https://ctdbase.org/detail.go?type=gene&acc=6747,,,6747.0,SSR3,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of SSR3 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
186,1456106,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,6812,STXBP1,https://ctdbase.org/detail.go?type=gene&acc=6812,,,6812.0,STXBP1,10116,Rattus norvegicus (Norway rat),Mesaconitine results in decreased expression of STXBP1 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
187,1456107,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,6612,SUMO3,https://ctdbase.org/detail.go?type=gene&acc=6612,,,6612.0,SUMO3,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of SUMO3 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
188,1456108,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10116,Rattus norvegicus (Norway rat),Mesaconitine results in decreased expression of SYN1 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
189,1456109,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,6876,TAGLN,https://ctdbase.org/detail.go?type=gene&acc=6876,,,6876.0,TAGLN,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of TAGLN protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
190,1456110,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,6895,TARBP2,https://ctdbase.org/detail.go?type=gene&acc=6895,,,6895.0,TARBP2,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of TARBP2 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
191,1456111,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,30071,TBX5A,https://ctdbase.org/detail.go?type=gene&acc=30071,,,30071.0,tbx5a,7955,Danio rerio (zebrafish),Mesaconitine results in decreased expression of TBX5A mRNA,,,PMID:30639578,https://www.ncbi.nlm.nih.gov/pubmed/30639578,30639578,,
192,1456112,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,9524,TECR,https://ctdbase.org/detail.go?type=gene&acc=9524,,,9524.0,TECR,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of TECR protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
193,1456113,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,7019,TFAM,https://ctdbase.org/detail.go?type=gene&acc=7019,,,7019.0,TFAM,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of TFAM protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
194,1456114,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,9967,THRAP3,https://ctdbase.org/detail.go?type=gene&acc=9967,,,9967.0,THRAP3,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of THRAP3 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
195,1456750,443382,Drug Gene Interaction database (DGIdb),Chloramphenicol Palmitate,,CHLORAMPHENICOL PALMITATE,https://www.dgidb.org/drugs/rxcui:20767,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606,Homo sapiens (human),,,,,,,,
196,1457077,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7R5,30S ribosomal protein S10,947807.0,rpmC,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
197,1457078,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7R9,30S ribosomal protein S11,83578282.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
198,1457079,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7S3,30S ribosomal protein S12,948425.0,rpmE,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
199,1457080,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7S9,30S ribosomal protein S13,75204609.0,rpmE,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
200,1457081,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7T3,30S ribosomal protein S16,944960.0,ykgM,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
201,1457544,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG59,30S ribosomal protein S14,947103.0,rpsP,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
202,1457545,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG63,30S ribosomal protein S17,83579843.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
203,1457546,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0AG67,30S ribosomal protein S1,948721.0,rpsR,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
204,1457547,443382,ChEMBL,Chloramphenicol Palmitate,CHEMBL1506,CHLORAMPHENICOL PALMITATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1506/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0C018,50S ribosomal protein L18,9735149.0,rpsR,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:6375931|PMID:16091044,https://www.ncbi.nlm.nih.gov/pubmed/6375931|https://www.ncbi.nlm.nih.gov/pubmed/16091044,6375931|16091044,,
205,1456950,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02358,30S ribosomal protein S6,948723.0,rpsF,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
206,1456951,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02359,30S ribosomal protein S7,947846.0,rpsG,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
207,1456952,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02413,50S ribosomal protein L15,947798.0,rplO,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
208,1456953,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7J3,50S ribosomal protein L10,948490.0,rplJ,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
209,1456954,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7K2,50S ribosomal protein L7/L12,948484.0,rplK,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
210,1456955,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7K6,50S ribosomal protein L19,83578990.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
211,1456956,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7L0,50S ribosomal protein L1,948489.0,rplL,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
212,1456957,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7L3,50S ribosomal protein L20,83578993.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
213,1456958,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7L8,50S ribosomal protein L27,947096.0,rplS,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
214,1457340,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7R9,30S ribosomal protein S11,83578282.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
215,1457341,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7S3,30S ribosomal protein S12,948425.0,rpmE,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
216,1458034,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P61175,50S ribosomal protein L22,947874.0,rpsB,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
217,1458035,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P62399,50S ribosomal protein L5,83577893.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
218,1458036,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68679,30S ribosomal protein S21,947814.0,rpsC,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
219,1458037,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P68919,50S ribosomal protein L25,84234843.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
220,1458038,443385,ChEMBL,Clindamycin Phosphate,CHEMBL3184512,CLINDAMYCIN PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3184512/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,Q2EEQ2,50S ribosomal protein L36 2,947793.0,rpsD,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:12860123,https://www.ncbi.nlm.nih.gov/pubmed/12860123,12860123,,
221,1457720,443388,BindingDB,,18771,"(2S)-2-[(4-{[(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}phenyl)formamido]pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18771,1876,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1876,P0ABQ4,Dihydrofolate reductase,944790.0,folA,83333,Escherichia coli K-12,,IC50 (nM),23000.0,PMID:18072727|DOI:10.1021/jm701052u,https://www.ncbi.nlm.nih.gov/pubmed/18072727|https://doi.org/10.1021/jm701052u,18072727,10.1021/jm701052u,
222,1457721,443388,BindingDB,,18771,"(2S)-2-[(4-{[(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}phenyl)formamido]pentanedioic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18771,9977,Bifunctional dihydrofolate reductase-thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9977,Q07422,Bifunctional dihydrofolate reductase-thymidylate synthase,,,5811,Toxoplasma gondii,,IC50 (nM),220.0,PMID:18072727|DOI:10.1021/jm701052u,https://www.ncbi.nlm.nih.gov/pubmed/18072727|https://doi.org/10.1021/jm701052u,18072727,10.1021/jm701052u,
223,1456447,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,25824,PRDX5,https://ctdbase.org/detail.go?type=gene&acc=25824,,,25824.0,PRDX5,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRDX5 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
224,1456448,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRDX6 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
225,1456449,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PRDX6 protein,,,PMID:21925251,https://www.ncbi.nlm.nih.gov/pubmed/21925251,21925251,,
226,1456450,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRDX6 mRNA,,,PMID:17450228,https://www.ncbi.nlm.nih.gov/pubmed/17450228,17450228,,
227,1456451,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of PRDX6 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
228,1456604,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,27166,PRELID1,https://ctdbase.org/detail.go?type=gene&acc=27166,,,27166.0,PRELID1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PRELID1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
229,1456605,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,393337,PRELID1A,https://ctdbase.org/detail.go?type=gene&acc=393337,,,393337.0,prelid1a,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRELID1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
230,1456606,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,553707,PRELID1B,https://ctdbase.org/detail.go?type=gene&acc=553707,,,553707.0,prelid1b,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRELID1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
231,1456751,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5551,PRF1,https://ctdbase.org/detail.go?type=gene&acc=5551,,,5551.0,PRF1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRF1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
232,1456752,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,559384,PRF1.5,https://ctdbase.org/detail.go?type=gene&acc=559384,,,559384.0,prf1.5,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRF1.5 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
233,1456753,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5553,PRG2,https://ctdbase.org/detail.go?type=gene&acc=5553,,,5553.0,PRG2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PRG2 protein,,,PMID:20050688,https://www.ncbi.nlm.nih.gov/pubmed/20050688,20050688,,
234,1456754,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10216,PRG4,https://ctdbase.org/detail.go?type=gene&acc=10216,,,10216.0,PRG4,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRG4 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
235,1456755,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10216,PRG4,https://ctdbase.org/detail.go?type=gene&acc=10216,,,10216.0,PRG4,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRG4 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
236,1456756,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,336351,PRG4A,https://ctdbase.org/detail.go?type=gene&acc=336351,,,336351.0,prg4a,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRG4A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
237,1456757,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,553377,PRG4B,https://ctdbase.org/detail.go?type=gene&acc=553377,,,553377.0,prg4b,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRG4B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
238,1456758,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PRICKLE1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
239,1456759,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,368249,PRICKLE1A,https://ctdbase.org/detail.go?type=gene&acc=368249,,,368249.0,prickle1a,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PRICKLE1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
240,1456760,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,556148,PRICKLE1B,https://ctdbase.org/detail.go?type=gene&acc=556148,,,556148.0,prickle1b,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRICKLE1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
241,1458196,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,67000,PRL3A1,https://ctdbase.org/detail.go?type=gene&acc=67000,,,67000.0,Prl3a1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRL3A1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
242,1458197,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,27372,PRL3C1,https://ctdbase.org/detail.go?type=gene&acc=27372,,,27372.0,Prl3c1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRL3C1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
243,1458198,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,28078,PRL5A1,https://ctdbase.org/detail.go?type=gene&acc=28078,,,28078.0,Prl5a1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRL5A1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
244,1458199,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,19113,PRL7A1,https://ctdbase.org/detail.go?type=gene&acc=19113,,,19113.0,Prl7a1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRL7A1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
245,1458200,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,19114,PRL7A2,https://ctdbase.org/detail.go?type=gene&acc=19114,,,19114.0,Prl7a2,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRL7A2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
246,1458201,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,73244,PRL8A1,https://ctdbase.org/detail.go?type=gene&acc=73244,,,73244.0,Prl8a1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRL8A1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
247,1458202,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,13529,PRL8A2,https://ctdbase.org/detail.go?type=gene&acc=13529,,,13529.0,Prl8a2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRL8A2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
248,1459078,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55879,GABRQ,https://ctdbase.org/detail.go?type=gene&acc=55879,,,55879.0,GABRQ,9606,Homo sapiens (human),Sodium arsenite affects the expression of GABRQ mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
249,1459079,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2569,GABRR1,https://ctdbase.org/detail.go?type=gene&acc=2569,,,2569.0,GABRR1,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GABRR1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
250,1459080,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2569,GABRR1,https://ctdbase.org/detail.go?type=gene&acc=2569,,,2569.0,GABRR1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of GABRR1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
251,1459081,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2571,GAD1,https://ctdbase.org/detail.go?type=gene&acc=2571,,,2571.0,GAD1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of GAD1 mRNA,,,PMID:22714537|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/22714537|https://www.ncbi.nlm.nih.gov/pubmed/29301061,22714537|29301061,,
252,1459082,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2571,GAD1,https://ctdbase.org/detail.go?type=gene&acc=2571,,,2571.0,GAD1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of GAD1 mRNA,,,PMID:20376865,https://www.ncbi.nlm.nih.gov/pubmed/20376865,20376865,,
253,1459083,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100329827,GAD1A,https://ctdbase.org/detail.go?type=gene&acc=100329827,,,100329827.0,gad1a,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GAD1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
254,1459084,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,378441,GAD1B,https://ctdbase.org/detail.go?type=gene&acc=378441,,,378441.0,gad1b,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GAD1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
255,1459085,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,182486,GAD-2,https://ctdbase.org/detail.go?type=gene&acc=182486,,,182486.0,gad-2,6239,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of GAD-2 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
256,1459238,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10594,PRPF8,https://ctdbase.org/detail.go?type=gene&acc=10594,,,10594.0,PRPF8,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRPF8 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
257,1459239,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PRPH mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
258,1459240,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRPH mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
259,1459241,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of PRPH protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
260,1459242,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606,Homo sapiens (human),Sodium arsenite affects the expression of PRPS1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
261,1459243,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PRPS1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
262,1459244,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2572,GAD2,https://ctdbase.org/detail.go?type=gene&acc=2572,,,2572.0,GAD2,9031,Gallus gallus (chicken),Sodium arsenite results in decreased expression of GAD2 mRNA,,,PMID:20308225,https://www.ncbi.nlm.nih.gov/pubmed/20308225,20308225,,
263,1459245,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2572,GAD2,https://ctdbase.org/detail.go?type=gene&acc=2572,,,2572.0,GAD2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of GAD2 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
264,1459246,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2572,GAD2,https://ctdbase.org/detail.go?type=gene&acc=2572,,,2572.0,GAD2,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of GAD2 mRNA,,,PMID:20376865,https://www.ncbi.nlm.nih.gov/pubmed/20376865,20376865,,
265,1459247,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606,Homo sapiens (human),[NCL protein mutant form results in decreased sumoylation of and affects the localization of NCL protein] inhibits the reaction [sodium arsenite results in increased stability of GADD45A mrna]|[ncl protein mutant form results in decreased sumoylation of and affects the localization of NCL protein] inhibits the reaction [sodium arsenite results in increased expression of GADD45A protein]|sod2 protein inhibits the reaction [sodium arsenite results in increased stability of GADD45A mrna]|sodium arsenite promotes the reaction [NCL protein modified form binds to and results in increased stability of GADD45A mrna]|ncl protein promotes the reaction [sodium arsenite results in increased expression of GADD45A protein]|sod2 protein inhibits the reaction [sodium arsenite results in increased expression of GADD45A protein]|sodium arsenite results in increased stability of GADD45A mRNA,,,PMID:25561743,https://www.ncbi.nlm.nih.gov/pubmed/25561743,25561743,,
266,1476524,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25828,TXN2,https://ctdbase.org/detail.go?type=gene&acc=25828,,,25828.0,TXN2,9606,Homo sapiens (human),Trichostatin A affects the expression of TXN2 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
267,1476525,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57544,TXNDC16,https://ctdbase.org/detail.go?type=gene&acc=57544,,,57544.0,TXNDC16,9606,Homo sapiens (human),Trichostatin A affects the expression of TXNDC16 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
268,1484083,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9938,ARHGAP25,https://ctdbase.org/detail.go?type=gene&acc=9938,,,9938.0,ARHGAP25,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of ARHGAP25 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
269,1484084,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,201176,ARHGAP27,https://ctdbase.org/detail.go?type=gene&acc=201176,,,201176.0,ARHGAP27,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ARHGAP27 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
270,1484085,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,115703,ARHGAP33,https://ctdbase.org/detail.go?type=gene&acc=115703,,,115703.0,ARHGAP33,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of ARHGAP33 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
271,1484086,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,394,ARHGAP5,https://ctdbase.org/detail.go?type=gene&acc=394,,,394.0,ARHGAP5,9606,Homo sapiens (human),Resveratrol results in decreased expression of ARHGAP5 protein|resveratrol results in decreased expression of ARHGAP5 mRNA,,,PMID:18089832,https://www.ncbi.nlm.nih.gov/pubmed/18089832,18089832,,
272,1549936,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,81539,SLC38A1,https://ctdbase.org/detail.go?type=gene&acc=81539,,,81539.0,SLC38A1,9606,Homo sapiens (human),Thapsigargin results in increased expression of SLC38A1 mRNA,,,PMID:22378314,https://www.ncbi.nlm.nih.gov/pubmed/22378314,22378314,,
273,1549937,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,54407,SLC38A2,https://ctdbase.org/detail.go?type=gene&acc=54407,,,54407.0,SLC38A2,9606,Homo sapiens (human),Thapsigargin results in increased expression of SLC38A2 mRNA,,,PMID:29453283,https://www.ncbi.nlm.nih.gov/pubmed/29453283,29453283,,
274,1549938,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,201266,SLC39A11,https://ctdbase.org/detail.go?type=gene&acc=201266,,,201266.0,SLC39A11,9606,Homo sapiens (human),Thapsigargin results in increased expression of SLC39A11 mRNA,,,PMID:22378314,https://www.ncbi.nlm.nih.gov/pubmed/22378314,22378314,,
275,1549939,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,9606,Homo sapiens (human),Thapsigargin results in increased expression of SLC3A2 mRNA,,,PMID:22378314|PMID:29453283,https://www.ncbi.nlm.nih.gov/pubmed/22378314|https://www.ncbi.nlm.nih.gov/pubmed/29453283,22378314|29453283,,
276,1549940,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,9606,Homo sapiens (human),Thapsigargin results in increased expression of SLC3A2 protein,,,PMID:29453283,https://www.ncbi.nlm.nih.gov/pubmed/29453283,29453283,,
277,1549941,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,10116,Rattus norvegicus (Norway rat),Thapsigargin results in increased expression of SLC3A2 protein,,,PMID:35544339,https://www.ncbi.nlm.nih.gov/pubmed/35544339,35544339,,
278,1549942,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,9497,SLC4A7,https://ctdbase.org/detail.go?type=gene&acc=9497,,,9497.0,SLC4A7,10090,Mus musculus (house mouse),Thapsigargin results in increased expression of SLC4A7 protein,,,PMID:24648495,https://www.ncbi.nlm.nih.gov/pubmed/24648495,24648495,,
279,1549943,446378,Comparative Toxicogenomics Database (CTD),Thapsigargin,D019284,Thapsigargin,https://ctdbase.org/detail.go?type=chem&acc=D019284,55974,SLC50A1,https://ctdbase.org/detail.go?type=gene&acc=55974,,,55974.0,SLC50A1,9606,Homo sapiens (human),Thapsigargin results in increased expression of SLC50A1 mRNA,,,PMID:22378314,https://www.ncbi.nlm.nih.gov/pubmed/22378314,22378314,,
280,1549840,1550884,Comparative Toxicogenomics Database (CTD),alpha-Hexylcinnamaldehyde,C080043,hexyl cinnamic aldehyde,https://ctdbase.org/detail.go?type=chem&acc=C080043,4097,MAFG,https://ctdbase.org/detail.go?type=gene&acc=4097,,,4097.0,MAFG,9606,Homo sapiens (human),Hexyl cinnamic aldehyde results in increased expression of MAFG mRNA,,,PMID:20566472,https://www.ncbi.nlm.nih.gov/pubmed/20566472,20566472,,
281,2002661,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,619331,ZFP551,https://ctdbase.org/detail.go?type=gene&acc=619331,,,619331.0,Zfp551,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ZFP551 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
282,2002662,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,243905,ZFP568,https://ctdbase.org/detail.go?type=gene&acc=243905,,,243905.0,Zfp568,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of ZFP568 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
283,2015236,23648488,BindingDB,"(5Z)-5-({4-[({3-[3-benzoyl-8-(trifluoromethyl)quinolin-4-yl]phenyl}amino)methyl]phenyl}methylidene)-1,3-thiazolidine-2,4-dione",20028,"(5Z)-5-({4-[({3-[3-benzoyl-8-(trifluoromethyl)quinolin-4-yl]phenyl}amino)methyl]phenyl}methylidene)-1,3-thiazolidine-2,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20028,2042,Oxysterols receptor LXR-beta [154-461],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2042,P55055,Oxysterols receptor LXR-beta,7376.0,NR1H2,9606,Homo sapiens (human),,IC50 (nM),276.0,PMID:17391964|DOI:10.1016/j.bmc.2007.03.013,https://www.ncbi.nlm.nih.gov/pubmed/17391964|https://doi.org/10.1016/j.bmc.2007.03.013,17391964,10.1016/j.bmc.2007.03.013,
284,2015245,23648493,BindingDB,"5-Bromo-6-(morpholin-4-yl)-1,3-diazinane-2,4-dione",20035,"5-bromo-6-(morpholin-4-yl)-1,3-diazinane-2,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20035,2044,Thymidine phosphorylase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2044,P07650,Thymidine phosphorylase,948901.0,deoA,83333,Escherichia coli K-12,,IC50 (nM),11600.0,PMID:16337119|DOI:10.1016/j.bmcl.2005.11.050,https://www.ncbi.nlm.nih.gov/pubmed/16337119|https://doi.org/10.1016/j.bmcl.2005.11.050,16337119,10.1016/j.bmcl.2005.11.050,
285,2015234,24739173,BindingDB,"7-[4-({[3-(2,6-Dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-1-naphthalenecarboxylic acid",30332,"Naphthoic acid-based analog, 1e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30332,2179,Bile acid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2179,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606,Homo sapiens (human),,,,PMID:18621523|DOI:10.1016/j.bmcl.2008.06.073,https://www.ncbi.nlm.nih.gov/pubmed/18621523|https://doi.org/10.1016/j.bmcl.2008.06.073,18621523,10.1016/j.bmcl.2008.06.073,
286,2015235,24739173,BindingDB,"7-[4-({[3-(2,6-Dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-1-naphthalenecarboxylic acid",30332,"Naphthoic acid-based analog, 1e",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30332,2179,Bile acid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2179,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606,Homo sapiens (human),,,,PMID:18621523|DOI:10.1016/j.bmcl.2008.06.073,https://www.ncbi.nlm.nih.gov/pubmed/18621523|https://doi.org/10.1016/j.bmcl.2008.06.073,18621523,10.1016/j.bmcl.2008.06.073,
287,2031257,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,22954,TRIM32,https://ctdbase.org/detail.go?type=gene&acc=22954,,,22954.0,TRIM32,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of TRIM32 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
288,2031258,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,55521,TRIM36,https://ctdbase.org/detail.go?type=gene&acc=55521,,,55521.0,TRIM36,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of TRIM36 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
289,2031259,25104564,Comparative Toxicogenomics Database (CTD),(3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide,C000590771,3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C000590771,286827,TRIM59,https://ctdbase.org/detail.go?type=gene&acc=286827,,,286827.0,TRIM59,9606,Homo sapiens (human),3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide results in decreased expression of TRIM59 mRNA,,,PMID:24102143,https://www.ncbi.nlm.nih.gov/pubmed/24102143,24102143,,
290,2038314,25227436,IUPHAR/BPS Guide to PHARMACOLOGY,Capivasertib,7709,capivasertib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7709,2286,AKT serine/threonine kinase 3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2286,Q9Y243,RAC-gamma serine/threonine-protein kinase,10000.0,AKT3,9606,Homo sapiens (human),Inhibition,pIC50,8.1,PMID:23394218,https://www.ncbi.nlm.nih.gov/pubmed/23394218,23394218,,
291,2038315,25229528,IUPHAR/BPS Guide to PHARMACOLOGY,"(1S,2S,3R,4R)-3-[5-Chloro-2-(1-ethyl-6-methoxy-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide",8220,compound 15 [PMID: 24900237],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8220,2273,unc-51 like kinase 3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2273,Q6PHR2,Serine/threonine-protein kinase ULK3,25989.0,ULK3,9606,Homo sapiens (human),Inhibition,,5.94,PMID:24900237,https://www.ncbi.nlm.nih.gov/pubmed/24900237,24900237,,
292,2038335,25254071,Comparative Toxicogenomics Database (CTD),Apitolisib,C569670,"1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one",https://ctdbase.org/detail.go?type=chem&acc=C569670,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,9606,Homo sapiens (human),"[PTEN gene mutant form co-treated with PIK3CA gene mutant form] results in increased susceptibility to 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one|pten gene mutant form results in increased susceptibility to 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one",,,PMID:23136191,https://www.ncbi.nlm.nih.gov/pubmed/23136191,23136191,,
293,2038336,25254071,Comparative Toxicogenomics Database (CTD),Apitolisib,C569670,"1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one",https://ctdbase.org/detail.go?type=chem&acc=C569670,6794,STK11,https://ctdbase.org/detail.go?type=gene&acc=6794,,,6794.0,STK11,9606,Homo sapiens (human),"STK11 gene mutant form results in increased susceptibility to 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one",,,PMID:23136191,https://www.ncbi.nlm.nih.gov/pubmed/23136191,23136191,,
294,2057091,51000408,Comparative Toxicogenomics Database (CTD),3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide,C560580,3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide,https://ctdbase.org/detail.go?type=chem&acc=C560580,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,9606,Homo sapiens (human),PTEN protein affects the susceptibility to [cisplatin co-treated with 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide],,,PMID:37802411,https://www.ncbi.nlm.nih.gov/pubmed/37802411,37802411,,
